Faruqi and Faruqui, LLP Logo
Share this page

Ekso Bionics Holdings, Inc. (EKSO)

(NASDAQ: EKSO)

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ekso Bionics Holdings, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ekso Bionics Holdings, Inc. (“Ekso Bionics” or the “Company”) (NASDAQ: EKSO).

On December 14, 2017, Ekso Bionics advised investors that “the Company’s internal control over financial reporting as of December 31, 2016 should no longer be relied upon and that a material weakness in the Company's internal control over financial reporting existed as of such date.”  Then on December 27, 2017, the Company filed an amended annual report for 2016 and amended quarterly reports for the first three quarters of 2017.

On this news, Ekso Bionics’ share price declined.

If you invested in Ekso Bionics stock or options and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn:  Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

 

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    Ekso Bionics Holdings, Inc. (EKSO)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 12/28/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.